TY - JOUR
KW - Cost benefit analysis
KW - Gay Persons -- Education
KW - Bisexuality -- Education
KW - Transgender Persons -- Education
KW - Contingency management
KW - Substance Abuse
KW - Patient Care -- Education
KW - Human
KW - Randomized Controlled Trials
KW - Sexual Partners
KW - Immunization
KW - Hepatitis A
KW - Hepatitis B Vaccines
KW - Costs and Cost Analysis
KW - Interviews
AU - S. X. Zhang
AU - S. Shoptaw
AU - C. J. Reback
AU - K. Yadav
AU - A. M. Nyamathi
A1 - 
AD - San Diego State University, Department of Sociology, San Diego, CA, USA; University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA; Friends Research Institute, Inc., University of California at Los Angeles, Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA; University of California at Irvine, Sue & Bill Gross School of Nursing, Irvine, CA, USA
BT - Public Health (Elsevier)
C5 - Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
CY - New York, New York
DO - 10.1016/j.puhe.2017.10.024
JF - Public Health (Elsevier)
LA - English
M1 - Journal Article
PB - Elsevier B.V
PP - New York, New York
PY - 2018
SN - 0033-3506
SP - 151
EP - 160
EP - 
T1 - Cost-effective way to reduce stimulant-abuse among gay/bisexual men and transgender women: a randomized clinical trial with a cost comparison
T2 - Public Health (Elsevier)
TI - Cost-effective way to reduce stimulant-abuse among gay/bisexual men and transgender women: a randomized clinical trial with a cost comparison
U1 - Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1016/j.puhe.2017.10.024
UR - https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=126995674&site=ehost-live
VL - 154
VO - 0033-3506
Y1 - 2018
Y2 - 01
ER -